NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.56 +0.17 (+7.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025)

Updated

NeuroSense Therapeutics (NRSN) recorded Operating Leases of $72,000 in Q4 2025.

Analysis

NeuroSense Therapeutics (NRSN) Operating Leases (2022 - 2025) Analysis & Trends

Starting with Q1 2022, NeuroSense Therapeutics' Operating Leases history includes 12 quarters.

  • Annual Operating Leases has a three-year compound annual growth rate of -21.2% (FY2022 to FY2025).
  • Across earlier years, Operating Leases came in at $73,000 in FY2023 (-50.3%) and $147,000 in FY2022.
  • The Q4 2025 figure is the highest quarterly Operating Leases since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 NeuroSense Therapeutics 3.19 Mn -1.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 72,000.00
Sep 30, 2024 19,000.00
Jun 30, 2024 36,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 73,000.00
Sep 30, 2023 84,000.00
Jun 30, 2023 104,000.00
Mar 31, 2023 126,000.00
Dec 31, 2022 147,000.00
Sep 30, 2022 173,000.00
Jun 30, 2022 190,000.00
Mar 31, 2022 207,000.00
API Access

NeuroSense Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NRSN&period=max&api_key=YOUR_API_KEY